Literature DB >> 4180816

Controlled trials of phenobarbitone therapy of neonatal jaundice.

C Ramboer, R P Thompson, R Williams.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4180816     DOI: 10.1016/s0140-6736(69)91862-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

1.  London letter.

Authors:  S S Gilder
Journal:  Can Med Assoc J       Date:  1970-02-14       Impact factor: 8.262

2.  Controlled trial of antenatal barbiturates in rhesus haemolytic disease.

Authors:  S H Towers; G P McMullin
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

3.  Vitamin E in neonatal hyperbilirubinaemia.

Authors:  B A Abrams; J M Gutteridge; J Stocks; M Friedman; T L Dormandy
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

4.  Relative roles of phototherapy and phenobarbitone in treatment of nonhaemolytic neonatal jaundice.

Authors:  Y K Wong; B S Wood
Journal:  Arch Dis Child       Date:  1973-09       Impact factor: 3.791

5.  Controlled trial of phenobarbitone in neonatal jaundice.

Authors:  G E Levin; G P McMullin; A N Mobarak
Journal:  Arch Dis Child       Date:  1970-02       Impact factor: 3.791

6.  Conjugation inhibitors and early neonatal hyperbilirubinaemia.

Authors:  A P Cole; T Hargreaves
Journal:  Arch Dis Child       Date:  1972-06       Impact factor: 3.791

7.  Sequential trial of effect of phenobarbitone on serum bilirubin of preterm infants.

Authors:  F Carswell; M M Kerr; I R Dunsmore
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

8.  Barbiturate treatment of neonatal icterus.

Authors:  A Dortmann; H Haupt; F Küster
Journal:  Z Kinderheilkd       Date:  1972

9.  Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

10.  Controlled trial of phetharbital, a non-hypnotic barbiturate, in unconugated hyperbilirubinaemia.

Authors:  J Hunter; R P Thompson; M O Rake; R Williams
Journal:  Br Med J       Date:  1971-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.